FDA announced approval of peramivir (Rapivab) for treatment of uncomplicated influenza in adults
On Dec. 22, 2014, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
BioCryst’s RAPIVAB(TM) (peramivir injection) received FDA approval for treatment of influenza in adults
On Dec. 22, 2014, BioCryst Pharmaceuticals announced the FDA had approved RAPIVAB (peramivir injection), an intravenous (i.v.) neuraminidase…
FDA approved quadrivalent formulation of Fluzone Intradermal inactivated influenza vaccine
On Dec. 12, 2014, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
Biotechnology | CDC | Influenza | Life Science News | Non-Profit Research | Radiology | Stem Cell | Vaccine
CDC published ACIP recommendations for prevention and control ofï¾ Haemophilus influenzaeï¾ type b (Hib) ï¾ disease
On Feb. 28, 2014, the U.S. Centers for Disease Control and Prevention (CDC) published Immunization Practices Advisory Committee…
Biotechnology | CDC | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
The CDC initiated the Global Heath Security Agenda
On Aug. 1, 2014, the U.S. Centers for Disease Control and Prevention (CDC) initiated the Global Heath Security…
CDC partnered with Public Health laboratories to define optimal size for influenza virologic surveillance
On Jul. 2, 2013 the U.S. Centers for Disease Control and Prevention (CDC) partnered with Association of Public…
ACIP voted to recommend FluBlok influenza vaccine for people age 18 through 49ï¾ with egg allergy
On Jun. 20, 2013, the Advisory Committee on Immunization Practices (ACIP) voted 13 to 0, in favor of…
FDA approved Fluzone as the third quadrivalent influenza vaccine licensed for US use
On Jun. 7, 2013, Sanofi Pasteur announced the FDA had approved the supplemental biologics license application (sBLA) for…
Texas A&M System and GlaxoSmithKline receive US Government approval to establish influenza vaccine facility In Texas
On Mar. 26, 2013, GlaxoSmithKline and the Texas A&M University System announced that the U.S. Department of Health…
FDA approved quadrivalent formulation of Fluarix
On Dec. 14, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved GlaxoSmithKline’s quadrivalent formulation…
A milestone in protection from influenza was reached with FDA approval for Novartis to manufacture seasonal influenza vaccine using cell-based technology in a US facility
On Nov. 20, 2012, the FDA approved a seasonal flu vaccine produced by Novartis using animal cell culture…
FDA approved first seasonal influenza vaccine manufactured using cell culture technology
On Nov. 20, 2012, the U.S. Food and Drug Administration (FDA) announced it had approved first seasonal influenza…
Biotechnology | Diagnostics | Influenza | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu
On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…
Vaccines containing cell-cultured virus became available
In 2012, vaccines containing cell-cultured virus became available. Even though eggs continued to be the primary means of…
FDA expanded use of Prevnar 13 vaccine to include people ages 50 and older
On Dec. 30, 2011, Pfizer announced that the U.S. Food and Drug Administration (FDA) had granted approval of…
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA | Vaccine
Novel Reassortant Highly Pathogenic Avian Influenza (H5N5) Viruses in Domestic Ducks, China
On Jun. 11, 2011, scientists in China reported the isolation of 2 novel reassortant highly pathogenic avian influenza…
WHO declared end to 2009 H1N1 influenza pandemic
On Aug. 10, 2010, WHO Director-General Dr Margaret Chan announced that the H1N1 influenza virus had moved into…
ACIP recommended universal Influenza vaccination for those 6 months of age and older
On Feb. 24, 2010, the Immunization Practices Advisory Committee (ACIP) recommended universal Influenza vaccination for those 6 months…
Biotechnology | Infectious Disease | Influenza | Life Science News | Non-Profit Research | Vaccine | WHO
Bill and Melinda Gates Foundation Pledged $10 Billion in Call for Decade of Vaccines
On Jan. 29, 2010, the Bill and Melinda Gates announced that their foundation will commit $10 billion over…
FDA approved high-dose inactivated influenza vaccine for people ages 65 years and older
On Dec. 23, 2009, the FDA approved high-dose inactivated influenza vaccine (Fluzone High-Dose) for people ages 65 years…
CDC recommended pneumococcal vaccination to help prevent secondary infections
On Nov. 16, 2009, the U.S. Centers for Disease Control and Prevention (CDC) recommended a single dose of…
swine flu outbreak declared a national emergency
On Oct. 24, 2009, President Barack Obama declared the swine flu (N1n1) outbreak a national emergency. The declaration…
FDA approved four vaccines against the 2009 H1N1 influenza virus
On Sept. 15, 2009, the U.S. Food and Drug Administration (FDA) approved four Influenza A (H1N1) 2009 Monovalent…
ACIP issued recommendations on the use of H1N1 influenza vaccines
On Jul. 31, 2009, the Immunization Practices Advisory Committee (ACIP) updates the 2008 recommendations regarding the use of…
HHS announced advanced development contract for new way to make flu vaccine
On Jun. 23, 2009, the U.S. Department of Health and Human Services (HHS) announced advanced development contract for…
WHO declared world at the start of 2009 influenza pandemic
On Jun. 11, 2009, the Dr. Margaret Chan, Director-General WHO, declared world now at the start of 2009…
HHS directed $1 billion toward development of vaccine for novel influenza A (H1N1)
On May 22, 2009, the U.S. Dept. of Health and Human Services (HHS) directed $1 billion toward development…
A novel influenza A (H1N1)pdm09 virus was detected first in the U.S. before spreading worldwide
On Apr. 15, 2009, a novel influenza A virus (then referred to as ‘swine origin influenza A virus’)…
Biotechnology | CDC | Diagnostics | Influenza | Life Science News | NIH | Therapeutics
CDC began a complex and multi-faceted response to the H1N1 pandemic
On Apr. 15, 2009, infection with the new influenza A virus (then referred to as ‘swine origin influenza…
The CDC identified the novel H1N1 influenza virus
On Apr. 15, 2009, the U.S. Centers for Disease Control and Prevention (CDC) identified the novel H1N1 influenza…